109 related articles for article (PubMed ID: 3203198)
1. Serum procollagen type III aminoterminal peptide in primary fibromyalgia (fibrositis syndrome).
Jensen LT; Jacobsen S; Hørsley-Petersen K
Br J Rheumatol; 1988 Dec; 27(6):496. PubMed ID: 3203198
[No Abstract] [Full Text] [Related]
2. Primary fibromyalgia: clinical parameters in relation to serum procollagen type III aminoterminal peptide.
Jacobsen S; Jensen LT; Foldager M; Danneskiold-Samsøe B
Br J Rheumatol; 1990 Jun; 29(3):174-7. PubMed ID: 2357497
[TBL] [Abstract][Full Text] [Related]
3. Increased serum procollagen III aminoterminal peptide in myelofibrosis.
Hochweiss S; Fruchtman S; Hahn EG; Gilbert H; Donovan PB; Johnson J; Goldberg JD; Berk PD
Am J Hematol; 1983 Dec; 15(4):343-51. PubMed ID: 6650494
[TBL] [Abstract][Full Text] [Related]
4. Serum aminoterminal propeptide of type III procollagen in psoriasis and psoriatic arthritis: relation to liver fibrosis and arthritis.
Zachariae H; Aslam HM; Bjerring P; Søgaard H; Zachariae E; Heickendorff L
J Am Acad Dermatol; 1991 Jul; 25(1 Pt 1):50-3. PubMed ID: 1880254
[TBL] [Abstract][Full Text] [Related]
5. Serum interleukin-6 level in patients with systemic sclerosis: lack of correlation with aminoterminal propeptide of type III procollagen.
Kucharz EJ; Jonderko G; Rubisz-Brzezinska J; Brzezinska-Wcisło L
Clin Rheumatol; 1995 May; 14(3):380-1. PubMed ID: 7641522
[No Abstract] [Full Text] [Related]
6. [Levels of procollagen type III n-terminal peptide (PIIINP) in serum of patients with myeloproliferative syndrome (mps)].
Podolak-Dawidziak M; Wróbel T; Jeleń M
Pol Arch Med Wewn; 1998 Jan; 99(1):24-9. PubMed ID: 9686500
[TBL] [Abstract][Full Text] [Related]
7. Modifications in bone-GLA protein (BGP) and aminoterminal propeptide of type III procollagen (PIIINP) levels in one patient with Cushing's syndrome.
Sartorio A; Ambrosi B; Conti A; Monzani M; Faglia G
Horm Metab Res; 1991 May; 23(5):247-9. PubMed ID: 1651897
[No Abstract] [Full Text] [Related]
8. Insulin-like growth factor-I raises serum procollagen levels in children and adults with Laron syndrome.
Klinger B; Jensen LT; Silbergeld A; Laron Z
Clin Endocrinol (Oxf); 1996 Oct; 45(4):423-9. PubMed ID: 8959080
[TBL] [Abstract][Full Text] [Related]
9. Elevated serum aminoterminal procollagen type III peptide in methotrexate-induced hepatic fibrosis.
Fairris GM; Brooks B; Tanner A
Br J Dermatol; 1986 Apr; 114(4):520-1. PubMed ID: 3964554
[No Abstract] [Full Text] [Related]
10. Collagen metabolism in gynecologic patients: changes in the concentration of the aminoterminal propeptide of type III procollagen in serum.
Puistola U; Risteli L; Risteli J; Kauppila A
Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 1):1276-81. PubMed ID: 2220941
[TBL] [Abstract][Full Text] [Related]
11. Aminoterminal propeptide of type-III procollagen in serum--an indicator of clinical behavior of advanced ovarian carcinoma?
Risteli L; Kauppila A; Mäkilä UM; Risteli J
Int J Cancer; 1988 Mar; 41(3):409-14. PubMed ID: 3346105
[TBL] [Abstract][Full Text] [Related]
12. Serum aminoterminal propeptide of type III procollagen in the management of methotrexate-induced fibrogenesis.
Kürkçüoğlu N; Oz G
J Am Acad Dermatol; 1992 Jul; 27(1):139. PubMed ID: 1619068
[No Abstract] [Full Text] [Related]
13. Aminoterminal propeptide of type III procollagen in methotrexate-induced liver fibrosis and cirrhosis.
Risteli J; Søgaard H; Oikarinen A; Risteli L; Karvonen J; Zachariae H
Br J Dermatol; 1988 Sep; 119(3):321-5. PubMed ID: 3179204
[TBL] [Abstract][Full Text] [Related]
14. Serum concentrations of laminin P1 and aminoterminal propeptide of type III procollagen in sickle cell disease.
Bolarin DM; Swerdlow P; Wallace AM; Littsey L
Haematologia (Budap); 1998; 29(1):51-8. PubMed ID: 9704258
[TBL] [Abstract][Full Text] [Related]
15. [The significance of aminoterminal procollagen type-III peptide in chronic hepatopathies].
Caballería J
Med Clin (Barc); 1992 May; 99(1):21-3. PubMed ID: 1602894
[No Abstract] [Full Text] [Related]
16. Elevated serum aminoterminal procollagen type-III-peptide parallels collagen accumulation in rats with secondary biliary fibrosis.
Gerling B; Becker M; Waldschmidt J; Rehmann M; Schuppan D
J Hepatol; 1996 Jul; 25(1):79-84. PubMed ID: 8836905
[TBL] [Abstract][Full Text] [Related]
17. Relationship of procollagen type III propeptide-related antigens in serum to somatic growth in healthy children and patients with growth disorders.
Danne T; Grüters A; Schuppan D; Quantas N; Enders I; Weber B
J Pediatr; 1989 Feb; 114(2):257-60. PubMed ID: 2915284
[No Abstract] [Full Text] [Related]
18. Procollagen Type I and III Aminoterminal Propeptide Levels and Severity of Interstitial Lung Disease in Mexican Women With Progressive Systemic Sclerosis.
Gonzalez-Lopez L; Rocha-Muñoz AD; Olivas-Flores EM; Garcia-Gonzalez A; Peguero-Gómez AR; Flores-Navarro J; Villa-Manzano AI; Zavaleta-Muñiz SA; Salazar-Paramo M; Mejía M; Juárez-Contreras P; Vazquez-Del Mercado M; Cardona-Muñoz EG; Trujillo-Hernández B; Nava-Zavala AH; Gamez-Nava JI
Arch Bronconeumol; 2015 Sep; 51(9):440-8. PubMed ID: 25301411
[TBL] [Abstract][Full Text] [Related]
19. [Serum aminoterminal procollagen type-III peptide in the diagnosis of chronic hepatopathies].
Solís-Herruzo JA; Morillas JD; Vargas J; Colina F; Castellano G; Muñoz Yagüe T; Estenoz J
Med Clin (Barc); 1992 May; 99(1):1-5. PubMed ID: 1602891
[TBL] [Abstract][Full Text] [Related]
20. Twenty-four-hour osteocalcin, carboxyterminal propeptide of type I procollagen, and aminoterminal propeptide of type III procollagen rhythms in normal and growth-retarded children.
Saggese G; Baroncelli GI; Bertelloni S; Cinquanta L; DiNero G
Pediatr Res; 1994 Apr; 35(4 Pt 1):409-15. PubMed ID: 8047377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]